stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Xenon Pharmaceuticals IncXENE
$38.853.27%1.23

Xenon Pharmaceuticals Inc (XENE)

Date: 2026-11-03 16:00O: 38.04H: 39.00L: 37.78C: 38.85Vol: 526.6k
Precedente Chiudi:
$37.62
Aprire:
$38.04
Volume 24 ore:
536,749
Volume relativo:
0.41
Capitalizzazione di mercato:
$3.76B
Reddito:
$7.50M
Utile/perdita netta:
-$383.17M
Rapporto P/E:
-
EPS:
-$4.70
Flusso di cassa netto:
-$307.84M
1W Prestazione:
+7.89%
1M Prestazione:
+2.18%
6M Prestazione:
-30.79%
1Y Prestazione:
-5.52%
Intervallo 1D:
$37.78$39.00
Intervallo di 1 settimana:
$35.37$38.35
Portata 52W:
$33.38$72.66

Profilo aziendale di Xenon Pharmaceuticals Inc (XENE)

Nome
Xenon Pharmaceuticals Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
(604) 484-3300
Indirizzo
200 - 3650 GILMORE WAY, BURNABY, Canada
Dipendente
370
X
-
Prossima data di guadagno
null
Ultimi documenti SEC
SEC
Discussioni di XENE su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Xenon Pharmaceuticals Inc Azioni (XENE) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-10-06ResumedGuggenheimBuy
2026-09-18DowngradeDeutsche BankBuy → Hold
2026-02-24IniziatoWolfe ResearchOutperform
2025-09-03ResumedWells FargoOverweight

Xenon Pharmaceuticals Inc Azioni (XENE) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)7.50-0.009.4318.44
Research and development USD (M)300.94210.39167.51105.7775.46
Operating expenses USD (M)380.57279.30214.05138.5897.43
Operating income USD (M)-373.07-279.30-214.05-129.14-78.99
Income before tax USD (M)-344.89-238.42-182.69-125.26-78.89
Income tax expense USD (M)1.02-4.09-0.290.12-0.01
Net income USD (M)-345.91-234.33-182.39-125.37-78.88
Basic EPS USD/shares-4.36-3.01-2.73-2.06-
Diluted EPS USD/shares-4.36-3.01-2.73-2.06-
Basic weighted shares shares (M)79.2577.8966.8960.54-
Diluted weighted shares shares (M)79.2577.8966.8960.54-

Xenon Pharmaceuticals Inc Azioni (XENE) insider trading

  • Chief Financial Officer
    Transazione
    Buy
    Costo
    $37.32
    #Azioni
    15,000
    Valore ($)
    559,740
    #Azioni Totale
    15,000
  • MORTIMER IANSep 30 '26
    PRESIDENT & CEO
    Transazione
    Buy
    Costo
    $37.38
    #Azioni
    30,000
    Valore ($)
    1,121,400
    #Azioni Totale
    49,923
  • Svoronos DawnSep 01 '26
    Director
    Transazione
    Option Exercise
    Costo
    $8.15
    #Azioni
    5,144
    Valore ($)
    41,924
    #Azioni Totale
    31,373
  • Officer
    Transazione
    Proposed Sale
    Costo
    $61.93
    #Azioni
    7,068
    Valore ($)
    437,721
    #Azioni Totale
    0
  • Chief Medical Officer
    Transazione
    Sale
    Costo
    $60.25
    #Azioni
    7,068
    Valore ($)
    425,829
    #Azioni Totale
    2
  • GANNON STEVENAug 11 '26
    Director
    Transazione
    Sale
    Costo
    $64.06
    #Azioni
    10,000
    Valore ($)
    640,550
    #Azioni Totale
    1,870
  • STEVEN GANNONAug 11 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $64.06
    #Azioni
    10,000
    Valore ($)
    640,553
    #Azioni Totale
    0
  • GARY PATOUJun 05 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $52.99
    #Azioni
    1,322
    Valore ($)
    70,053
    #Azioni Totale
    0
  • PATOU GARYJun 05 '26
    Director
    Transazione
    Sale
    Costo
    $53.14
    #Azioni
    1,322
    Valore ($)
    70,251
    #Azioni Totale
    24,896
  • Cannon GillianJun 05 '26
    Director
    Transazione
    Sale
    Costo
    $53.14
    #Azioni
    1,190
    Valore ($)
    63,237
    #Azioni Totale
    1,455
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Kelly Thomas PatrickChief Financial OfficerSep 30 '26Buy$37.3215,000559,74015,000
MORTIMER IANPRESIDENT & CEOSep 30 '26Buy$37.3830,0001,121,40049,923
Svoronos DawnDirectorSep 01 '26Option Exercise$8.155,14441,92431,373
CHRISTOPHER KENNEYOfficerAug 28 '26Proposed Sale$61.937,068437,7210
KENNEY CHRISTOPHER JOHNChief Medical OfficerAug 28 '26Sale$60.257,068425,8292
GANNON STEVENDirectorAug 11 '26Sale$64.0610,000640,5501,870
STEVEN GANNONDirectorAug 11 '26Proposed Sale$64.0610,000640,5530
GARY PATOUDirectorJun 05 '26Proposed Sale$52.991,32270,0530
PATOU GARYDirectorJun 05 '26Sale$53.141,32270,25124,896
Cannon GillianDirectorJun 05 '26Sale$53.141,19063,2371,455

Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie

Oct 25, 2026
Oct 25, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 23, 2026
Oct 23, 2026
Oct 22, 2026
Oct 22, 2026
Oct 21, 2026
Oct 21, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 17, 2026
Oct 17, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 14, 2026
Oct 14, 2026
Oct 13, 2026
Oct 13, 2026
Oct 12, 2026
Oct 12, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 10, 2026
Oct 10, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 07, 2026
Oct 07, 2026
Oct 07, 2026
Oct 07, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 03, 2026
Oct 03, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 30, 2026
Sep 30, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 24, 2026
Sep 24, 2026

Simile a XENE